Cargando…

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is the most prevalent form of dementia and represents one of the highest unmet requirements in medicine today. There is shortage of novel molecules entering into market because of poor pharmacokinetic properties and safety issues. Drug repurposing offers an oppor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Shivani, Chowdhury, Suman, Kumar, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660441/ https://www.ncbi.nlm.nih.gov/pubmed/29078760 http://dx.doi.org/10.1186/s12868-017-0394-8

Ejemplares similares

In vitro anti-acetylcholinesterase activity of an aqueous extract of Unicaria tomentosa and in silico study of its active constituents
por: Chowdhury, Suman, et al.
Publicado: (2016)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)

Repurposing Antipsychotics for Cancer Treatment
por: Vlachos, Nikolaos, et al.
Publicado: (2021)

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis
por: Papadopoulou, Dimitra, et al.
Publicado: (2023)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer’s Disease Patients and In Silico Prediction of Potential Repurposable Drugs
por: Fagone, Paolo, et al.
Publicado: (2022)

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

Network-based stage-specific drug repurposing for Alzheimer’s disease
por: Savva, Kyriaki, et al.
Publicado: (2022)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
por: Sekaran, Saravanan, et al.
Publicado: (2023)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
por: Wu, Chong, et al.
Publicado: (2021)

Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network
por: Soleimani Zakeri, Negar Sadat, et al.
Publicado: (2021)

The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease
por: Podsiedlik, Maria, et al.
Publicado: (2022)

In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
por: Thirunavukkarasu, Muthu Kumar, et al.
Publicado: (2021)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
por: Bourdakou, Marilena M., et al.
Publicado: (2023)

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020)

Repurposing of Tibolone in Alzheimer’s Disease
por: Barreto, George E.
Publicado: (2023)

Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study
por: Pathak, Yamini, et al.
Publicado: (2021)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
por: Calsolaro, Valeria, et al.
Publicado: (2019)

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
por: Shah, Bhumi, et al.
Publicado: (2020)

In silico drug repurposing in COVID-19: A network-based analysis
por: Sibilio, Pasquale, et al.
Publicado: (2021)

Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy
por: Wu, Chia-Hsien, et al.
Publicado: (2016)

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022)

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease
por: Jang, Ha Young, et al.
Publicado: (2022)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
por: Rácz, Bálint, et al.
Publicado: (2023)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections
por: Heemskerk, M. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oe918cs90nsr3gskl21im1h5hk